Filing summary
Entity and period: The supplied filing is Ecology Coatings, Inc.’s Form 10-K for the fiscal year ended September 30, 2012, not an ABVC Biopharma filing. It reports annual results, not results for 2012 Q4 alone. The report was signed April 15, 2015, and describes a business that later entered Chapter 7 bankruptcy.
Business context and financial results
Before bankruptcy, the company developed UV-curable coatings for applications including paper and packaging, metals, plastics, glass, electronics, and medical devices. Management said licensing and product sales had not generated substantial revenue; the company reported that one customer accounted for all revenue in both fiscal 2012 and 2011.
| Metric | FY 2012 | FY 2011 |
|---|---|---|
| Revenue | $5,714 | $3,190 |
| Operating expenses | $1,148,760 | $1,891,053 |
| Operating loss | $(1,143,046) | $(1,887,863) |
| Debt forgiveness income | $228,802 | $872,861 |
| Interest expense | $(87,698) | $(204,917) |
| Net loss | $(1,069,579) | $(1,218,651) |
| Net loss attributable to common shareholders | $(1,539,443) | $(3,009,482) |
| Basic and diluted loss per share | $(0.04) | $(0.31) |
| Net cash used in operating activities | $(915,124) | $(1,593,182) |
| Cash at year-end | $13,386 | $71,784 |
Revenue remained immaterial despite increasing year over year. Operating expenses fell by about $742,000, which management attributed largely to lower wages and compensation; professional fees fell about $75,000. The net loss improved by about $149,000, but the common-shareholder loss also reflects preferred-stock-related charges. No gross margin is clearly reported.
Financial position and liquidity
At September 30, 2012, total assets were $302,308, current assets $48,336, current liabilities $1,946,086, and stockholders’ deficit $1,643,778. The resulting working-capital deficit was approximately $1.90 million. Current liabilities included $604,330 in judgment payable, $1,115,698 in related-party notes payable, $140,752 in interest payable, and $80,842 in accounts payable and accrued expenses. The filing does not provide a clear consolidated total for all debt separate from other liabilities.
Operating cash use was partly offset by $876,272 of financing cash inflows, including $655,000 from preferred stock and $221,272 from debt issuance. Cash declined by $58,398 during the year. The company reported no income-tax benefit from loss carryforwards in the results, and its net deferred tax asset was fully offset by a valuation allowance.
Material changes, outlook, and risks
- The company reported $228,802 of debt-forgiveness income in FY 2012, down from $872,861 in FY 2011. It also reported a $604,330 judgment arising from litigation over notes carrying 25% interest.
- Preferred-stock conversions and issuances materially changed the share count. The balance sheet reports 54,593,032 common shares outstanding at September 30, 2012, while another section states 37,685,333 shares beneficially outstanding on that date.
- The auditor’s report included a going-concern emphasis, stating that losses, operating cash use, and accumulated deficit raised substantial doubt about the company’s ability to continue. The financial statements were not adjusted for possible consequences of that uncertainty.
- The filing says the company filed for Chapter 7 on May 15, 2013 and emerged on September 19, 2014 with the corporate shell as its only unencumbered asset and liabilities settled. A risk-factor passage instead gives a May 15, 2012 bankruptcy date, an apparent inconsistency.
- Management identified risks including limited capital, inability to commercialize technology or reach profitability, competition, dependence on customers and suppliers, and challenges maintaining intellectual property and operations. The filing provides no operating guidance or quantified outlook.
- Disclosure controls and internal control over financial reporting were reported ineffective at September 30, 2012. Management cited inadequate monitoring and lack of segregation of duties in a one-person financial staff.
Important facts for investors to verify
- Confirm the issuer: this filing is for Ecology Coatings, Inc., whereas the request metadata names ABVC Biopharma, Inc.
- Reconcile the conflicting common-share counts reported for September 30, 2012 and verify the effects of preferred conversions, issuances, and the later bankruptcy agreement.
- Confirm the bankruptcy filing date and the settlement and emergence terms; the filing gives inconsistent dates in different sections.
- Review the underlying audited statements and notes for debt, related-party obligations, litigation judgments, and the going-concern uncertainty. The filing contains inconsistencies and later bankruptcy disclosures that materially change the relevance of the 2012 operating business.
- Check the company’s subsequent filings and current corporate status before relying on the historical business description or securities information.